TSLNC8 interacted with HuR, facilitating HuR's binding to CTNNB1 mRNA and enhancing its stability, ultimately activating the WNT/β-catenin signaling pathway and promoting aggressiveness in pancreatic cancer cells. Here, ELAVL1 is linked to familial pancreatic carcinoma.